Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 08, 2026
ASML Holding (ASML) Holds Near Flat at -0.3% Over 30 Days Despite Robust AI-Driven Outlook

ASML Holding (ASML) Holds Near Flat at -0.3% Over 30 Days Despite Robust AI-Driven Outlook

Key Takeaways

  • ASML shares posted a net decline of approximately 0.3% over the trailing 30 days, closing at $1,757.09 on July 24, 2026, despite swinging nearly 15% peak-to-trough within the same window.
  • The company reported standout Q2 2026 results on July 15, with revenue of €9.33 billion and net income of €2.92 billion, both comfortably above consensus estimates.
  • Full-year 2026 revenue guidance was raised sharply to €43–€45 billion, up from €36–€40 billion previously, fueled by surging AI-driven demand for advanced logic and memory chips.
  • ASML announced plans to expand Low-NA EUV and DUV immersion capacity by 30% in each of the next two years, with 2027 EUV production capacity already nearly fully booked.
  • A brewing pricing dispute with top customer TSMC and ongoing U.S.-led export controls on China remain key uncertainties capping near-term price momentum.

Market Snapshot: ASML's Recent Trading Range

ASML Holding shares have traded in a notably volatile range over the past 30 days. After climbing to a 52-week high of $1,999.96 on June 30, the stock pulled back sharply in early July before rebounding around the company's Q2 earnings release. The July 15 report initially sent shares higher in premarket and intraday trading, but gains were rapidly pared as investors absorbed reports of pricing pushback from TSMC and broader geopolitical concerns. By July 24, ASML closed at $1,757.09—essentially flat versus the $1,762.77 closing price recorded on June 24. The sideways action, despite fundamentally strong results, reflects a market weighing exceptional AI-driven demand against elevated valuation multiples, customer pricing negotiations, and external regulatory risk. I checked comparable names in the sector using Tickeron’s AI Screener to put the relative performance in context.

ASML Holding (ASML) Business Overview and Competitive Position

ASML Holding N.V., headquartered in Veldhoven, Netherlands, is the world's sole supplier of extreme ultraviolet (EUV) lithography systems—multi-hundred-million-dollar machines indispensable for manufacturing the most advanced semiconductor chips. The company also produces deep ultraviolet (DUV) lithography equipment, metrology and inspection systems, and generates substantial recurring revenue from its Installed Base Management segment, which encompasses service contracts, performance upgrades, and field options. ASML's customer base includes virtually every leading-edge chipmaker: TSMC, Intel, Samsung, SK Hynix, and Micron. Its monopolistic position in EUV lithography—protected by decades of R&D investment, deep supplier relationships with firms such as Zeiss and Trumpf, and massive capital barriers to entry—makes ASML one of the most strategically vital companies in the global technology supply chain.

Recent Developments Driving ASML

The dominant event of the past 30 days was ASML's Q2 2026 earnings release on July 15. The company delivered total net sales of €9.33 billion, beating consensus estimates by approximately €500 million, while net income of €2.92 billion exceeded analyst forecasts by roughly €300 million. Gross margin reached 54%, at the upper end of guidance, supported by stronger-than-expected Installed Base Management sales, which contributed €2.8 billion in the quarter.

CEO Christophe Fouquet described order intake as "extremely strong" through the first half of 2026 and emphasized that customers are accelerating capacity expansion plans to meet AI infrastructure demand. In response, management raised full-year 2026 revenue guidance to €43–€45 billion—marking the second upward revision this year—and outlined aggressive manufacturing expansion: a 30% increase in Low-NA EUV output planned for 2027, with a further 30% increase under evaluation for 2028, alongside parallel capacity hikes for DUV immersion systems.

A significant technological milestone was also confirmed: Intel is now using ASML's High-NA EUV system on its Intel 18A process node to manufacture select Core Ultra Series 3 processors, representing the first commercial deployment of the next-generation lithography platform.

Offsetting the bullish operational momentum, reports surfaced that TSMC is pushing back against ASML's efforts to raise EUV system prices. CFO Roger Dassen acknowledged on the earnings call that while the current demand environment provides greater pricing flexibility, changes would not take effect immediately due to long order lead times. Additionally, proposed U.S. legislation seeking to tighten export restrictions on semiconductor equipment to China remains a persistent overhang, even as ASML reiterated that China should account for approximately 20% of 2026 sales, predominantly through DUV tools for mainstream logic applications. From what I see, monitoring these negotiations will be key in the months ahead.

2026 Outlook and What Investors Should Watch

Looking ahead, ASML's trajectory will be shaped by several interconnected factors. On the demand side, the pace of AI infrastructure investment by hyperscalers and chipmakers will remain the central driver. ASML's raised guidance already embeds aggressive growth assumptions—including approximately 45% growth in EUV business and 75% growth in memory-related revenue—and execution against these targets will be closely scrutinized. The company's ability to deliver on its planned 30% annual capacity increases, while managing supply-chain constraints for critical components such as Zeiss optics, represents a key operational risk.

The outcome of pricing negotiations with TSMC and other major customers will have significant implications for gross margin trajectory beyond 2026. Meanwhile, geopolitical developments—particularly the scope and enforcement of U.S.-led export controls targeting China—could materially alter ASML's addressable market for DUV systems. On the technology front, the pace of High-NA EUV adoption beyond Intel will be an important signal for the company's next growth cycle. ASML's next Capital Markets Day, scheduled for June 10, 2027, is expected to provide updated long-term financial targets that may reset investor expectations. I also reviewed broader sector signals with Tickeron’s AI Trend Prediction Engine to gauge how these factors might play out across peers.

Using Data-Driven Tools for Deeper Analysis

In my own research process, I find value in supplementing traditional analysis with automated signals. Tickeron’s AI Trading Bots platform provides access to a range of strategies that can be reviewed alongside fundamental developments like those at ASML. This approach helps cross-check conviction levels without replacing core due diligence.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ASML

Contributor

<p>Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years&nbsp;developing&nbsp;his proprietary trading and quantitative algorithms (now Tickeron&rsquo;s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional,&nbsp;sophisticated stock market analysis capabilities to retail investors via&nbsp;an easy-to-use interface.</p>


ASML's RSI Indicator climbs out of oversold territory

The RSI Indicator for ASML moved out of oversold territory on July 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In of the 25 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 61 cases where ASML's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ASML just turned positive on August 07, 2026. Looking at past instances where ASML's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ASML advanced for three days, in of 315 cases, the price rose further within the following month. The odds of a continued upward trend are .

ASML may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ASML as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

ASML moved below its 50-day moving average on July 27, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ASML crossed bearishly below the 50-day moving average on July 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASML declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ASML entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 63, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ASML’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ASML's P/B Ratio (26.525) is slightly higher than the industry average of (8.521). P/E Ratio (59.287) is within average values for comparable stocks, (191.168). Projected Growth (PEG Ratio) (2.095) is also within normal values, averaging (1.595). Dividend Yield (0.005) settles around the average of (0.006) among similar stocks. P/S Ratio (16.474) is also within normal values, averaging (37.902).

Notable companies

The most notable companies in this group are Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 65.22B. The market cap for tickers in the group ranges from 555.66K to 663.5B. ASML holds the highest valuation in this group at 663.5B. The lowest valued company is AVSR at 555.66K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 9%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 53%. AXTI experienced the highest price growth at 47%, while SMTK experienced the biggest fall at -28%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was -47%. For the same stocks of the Industry, the average monthly volume growth was -40% and the average quarterly volume growth was -68%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 32
Price Growth Rating: 42
SMR Rating: 74
Profit Risk Rating: 62
Seasonality Score: -24 (-100 ... +100)
View a ticker or compare two or three
ASML
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of technology systems for the semiconductor industry

Industry ElectronicProductionEquipment

Profile
Details
Industry
Electronic Production Equipment
Address
De Run 6501
Phone
+31 402683000
Employees
44000
Web
https://www.asml.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
ASML Holding (ASML) Holds Near Flat at -0.3% Over 30 Days Despite Robust AI-Driven Outlook